Organogenesis Holdings (ORGO) Total Current Liabilities (2015 - 2026)

Organogenesis Holdings' Total Current Liabilities history runs 12 years deep, the most recent figure standing at $76.0 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 16.86% year-over-year to $76.0 million in Q1 2026; TTM through Mar 2026 was $76.0 million, a 16.86% increase from a year earlier, with the FY2025 full-year figure at $100.1 million, up 29.23% from the prior year.
• Total Current Liabilities retreated to $76.0 million in Q1 2026 per ORGO's latest filing, from $100.1 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $100.1 million in Q4 2025 and bottomed at $65.1 million in Q1 2025.
• The 5-year median for Total Current Liabilities is $78.5 million (2022), against an average of $80.2 million.
• Biggest YoY gain for Total Current Liabilities was 29.23% in 2025; the steepest drop was 23.2% in 2025.
• Year by year, Total Current Liabilities stood at $75.0 million in 2022, then grew by 7.31% to $80.5 million in 2023, then dropped by 3.77% to $77.5 million in 2024, then advanced by 29.23% to $100.1 million in 2025, then fell by 24.07% to $76.0 million in 2026.
• Per Business Quant, the three latest ORGO Total Current Liabilities figures stand at $76.0 million (Q1 2026), $100.1 million (Q4 2025), and $90.3 million (Q3 2025).